Genoxyn Platform

Molecular Synthesis & Quantum Bio-Simulation

Pioneering quantum-phonon chip technology for programmable molecular assembly with unprecedented precision in molecular design and biological simulation.

DNA/RNA Synthesis
Q-PHONON Technology
Bio-Computing

Who We Serve

Biotechnology organizations requiring precision molecular engineering and simulation

Biotech Companies

Synthetic biology, gene therapy development, custom DNA synthesis

Pharmaceutical Research

Protein engineering, molecular modeling, drug discovery pipelines

Genomics Labs

Gene synthesis, molecular data storage, DNA sequencing research

Synthetic Biology

Programmable gene assembly, bio-computing, molecular circuit design

Why Genoxyn?

Traditional DNA synthesis faces critical limitations in length, accuracy, and scalability.

Our Q-PHONON quantum-phonon chip technology represents a fundamental breakthrough in programmable molecular assembly. Using quantum interference control at the nanoscale, we enable direct synthesis of complex DNA/RNA sequences and proteins with unprecedented fidelity.

Every synthesis is controlled at the molecular level with complete traceability. Every reaction is reproducible. Every output is verifiable. This isn't optional in molecular engineering—it's foundational.

Q-PHONON Quantum Control

Quantum-phonon interference enables phononic band gap manipulation for precise molecular assembly with error rates below 0.01%.

Bio-Computing Infrastructure

Programmable molecular circuits and DNA-based computation platforms for next-generation biological information processing.

Molecular Data Storage

DNA-based data storage systems with multi-petabyte density and century-scale durability for archival applications.

Real-World Applications

From artificial gene synthesis to bio-computing—infrastructure for molecular design

Artificial DNA/RNA Synthesis

Programmable Gene Assembly: Synthesize custom DNA/RNA sequences up to 10kb with quantum-controlled precision for gene therapy and synthetic biology.

High-Fidelity Synthesis: Q-PHONON technology achieves 99.99%+ accuracy per nucleotide with complete sequence verification.

→ Typical synthesis time: Minutes to hours vs. days with traditional methods

Protein Engineering & Structure

De Novo Protein Design: Engineer novel proteins with specified functions using quantum-guided molecular folding simulation.

Structure Prediction: AlphaFold-integrated pipelines with quantum refinement for therapeutic protein development.

→ Accelerates drug discovery and enzyme engineering by 100x

Q-PHONON Quantum Bio-Simulation

Molecular Dynamics: Quantum-enhanced simulation of protein-ligand interactions, enzyme reactions, and metabolic pathways.

Phononic Control: Manipulate phononic band gaps for thermal management and reaction optimization at the nanoscale.

→ Enables simulation scale and accuracy previously impossible

Molecular Data Storage

DNA Storage Systems: Encode digital data into DNA sequences with error correction for ultra-high-density archival storage.

Bio-Computing: Programmable molecular circuits and DNA-based logic gates for biological information processing.

→ 1 exabyte per gram storage density with century-scale stability

What Sets Us Apart

Purpose-built quantum bio-infrastructure—not conventional chemical synthesis

01
Quantum-Phonon Control

Q-PHONON chip architecture uses quantum interference and phononic band gap manipulation to achieve molecular-level synthesis control impossible with traditional methods.

02
Programmable Assembly

Digital control of molecular assembly enables rapid prototyping and iteration. Design sequences in silico and synthesize them in hours, not weeks.

03
Integrated Bio-SaaS

Cloud-accessible simulation and synthesis platform. Design, simulate, and order molecular constructs through unified API with complete workflow automation.

Development Status

Genoxyn is currently in advanced pre-production development. Our Q-PHONON chip technology has been validated through comprehensive simulation and we are building towards commercial release with expected initial launch in Q3 2026.

Our infrastructure is designed for molecular-grade precision from day one—architecting quantum control into the foundation, not retrofitting it afterward.

Pre-Production Development
Q3 2026 Target Launch